Amanote Research
Register
Sign In
Erratum To: PKM2 and ACVR 1C Are Prognostic Markers for Poor Prognosis of Gallbladder Cancer
Clinical and Translational Oncology
- Italy
doi 10.1007/s12094-013-1123-0
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Cancer Research
Oncology
Date
October 26, 2013
Authors
J. Li
Z. Yang
Q. Zou
Y. Yuan
J. Li
L. Liang
G. Zeng
S. Chen
Publisher
Springer Science and Business Media LLC
Related search
ECT2 Associated to PRICKLE1 Are Poor-Prognosis Markers in Triple-Negative Breast Cancer
British Journal of Cancer
Cancer Research
Oncology
Up-Regulation of PKM2 Promote Malignancy and Related to Adverse Prognostic Risk Factor in Human Gallbladder Cancer
Scientific Reports
Multidisciplinary
PKM2 Regulates Neural Invasion of and Predicts Poor Prognosis for Human Hilar Cholangiocarcinoma
Molecular Cancer
Cancer Research
Oncology
Molecular Medicine
Investigation of RIP140 and LCoR as Independent Markers for Poor Prognosis in Cervical Cancer
Oncotarget
Oncology
A High Monocyte-To-Lymphocyte Ratio Predicts Poor Prognosis in Patients With Advanced Gallbladder Cancer Receiving Chemotherapy
Cancer Epidemiology Biomarkers and Prevention
Medicine
Epidemiology
Oncology
SMAD4 Alteration Associates With Invasive-Front Pathological Markers and Poor Prognosis in Colorectal Cancer
Histopathology
Medicine
Forensic Medicine
Pathology
Histology
Breast Cancer Prognostic Markers: Are They Really Addressing the Issues?
Biosafety
CD146 Expression Correlates With Epithelial-Mesenchymal Transition Markers and a Poor Prognosis in Gastric Cancer
International Journal of Molecular Sciences
Organic Chemistry
Molecular Biology
Theoretical Chemistry
Inorganic Chemistry
Computer Science Applications
Spectroscopy
Medicine
Catalysis
Physical
Hyperuricemia and Untreated Gout Are Poor Prognostic Markers Among Those With a Recent Acute Myocardial Infarction
Arthritis Research and Therapy
Rheumatology
Allergy
Immunology